CY1106973T1 - Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms) - Google Patents

Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms)

Info

Publication number
CY1106973T1
CY1106973T1 CY20071101413T CY071101413T CY1106973T1 CY 1106973 T1 CY1106973 T1 CY 1106973T1 CY 20071101413 T CY20071101413 T CY 20071101413T CY 071101413 T CY071101413 T CY 071101413T CY 1106973 T1 CY1106973 T1 CY 1106973T1
Authority
CY
Cyprus
Prior art keywords
androgen
thaizolin
sarms
conductors
products
Prior art date
Application number
CY20071101413T
Other languages
English (en)
Inventor
Raymond A Ng
Zhihua Sui
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of CY1106973T1 publication Critical patent/CY1106973T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • AIDS & HIV (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Η παρούσα εφεύρεσις αναφέρεται εις νέα παράγωγα θειαζολίνης του γενικού τύπου (Ι)˙ εις τον οποίον όλες οι μεταβλητές είναι ως καθορίζονται ενταύθα, φαρμακευτικαί συνθέσεις περιέχουσαι αυτά και χρήσις των εις την θεραπείαν διαταραχών και καταστάσεων διαμορφωμένων υπό του υποδοχέως ανδρογόνου.
CY20071101413T 2003-06-13 2007-11-05 Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms) CY1106973T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47871203P 2003-06-13 2003-06-13
EP04755044A EP1656360B1 (en) 2003-06-13 2004-06-12 Thiazoline derivatives as selective androgen receptor modulators (sarms)

Publications (1)

Publication Number Publication Date
CY1106973T1 true CY1106973T1 (el) 2012-09-26

Family

ID=33539114

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101413T CY1106973T1 (el) 2003-06-13 2007-11-05 Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms)

Country Status (14)

Country Link
US (1) US20050014952A1 (el)
EP (1) EP1656360B1 (el)
JP (1) JP4898446B2 (el)
CN (1) CN1835937B (el)
AT (1) ATE370133T1 (el)
AU (1) AU2004249697B2 (el)
CA (1) CA2528764A1 (el)
CY (1) CY1106973T1 (el)
DE (1) DE602004008300T2 (el)
DK (1) DK1656360T3 (el)
ES (1) ES2291906T3 (el)
PL (1) PL1656360T3 (el)
PT (1) PT1656360E (el)
WO (1) WO2004113309A1 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104803916B (zh) 2004-11-16 2017-08-11 詹森药业有限公司 用作选择性雄激素受体调节剂(sarms)的杂环衍生物
US7709516B2 (en) 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
US9284345B2 (en) 2007-04-12 2016-03-15 Endorecherche, Inc. 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
EP2802608A4 (en) * 2012-01-12 2015-08-05 Univ Yale COMPOUNDS AND METHODS FOR ENHANCED DEGRADATION OF TARGET PROTEINS AND OTHER POLYPEPTIDES BY E3 UBIQUITIN LIGASE
CN103450112B (zh) * 2013-08-07 2019-09-13 华东理工大学 一种n-桥连接的含氮五元杂环化合物及其制备与用途
US9682960B2 (en) 2013-12-19 2017-06-20 Endorecherche, Inc. Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
CN113811333B (zh) 2019-05-14 2024-03-12 诺维逊生物股份有限公司 靶向抗癌核激素受体的化合物
US11952349B2 (en) 2019-11-13 2024-04-09 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
IL306010A (en) 2021-03-23 2023-11-01 Nuvation Bio Inc Anticancer compounds against the nuclear hormone receptor
US12006314B2 (en) 2021-05-03 2024-06-11 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9506625A (pt) * 1994-01-24 1997-09-30 Du Pont Composto composição artropodicida e método para controle de artrópodos
US6403623B1 (en) * 1999-05-27 2002-06-11 Unuversity Of Notre Dame Du Lac Heterocyclic antituberculosis agents
EA014224B1 (ru) * 2000-08-24 2010-10-29 Юниверсити Оф Теннесси Рисерч Фаундейшн Селективные модуляторы андрогенового рецептора и способы их применения

Also Published As

Publication number Publication date
JP4898446B2 (ja) 2012-03-14
EP1656360B1 (en) 2007-08-15
JP2007501287A (ja) 2007-01-25
CN1835937B (zh) 2012-07-18
AU2004249697B2 (en) 2010-04-22
CN1835937A (zh) 2006-09-20
ES2291906T3 (es) 2008-03-01
DE602004008300T2 (de) 2008-05-08
CA2528764A1 (en) 2004-12-29
DK1656360T3 (da) 2007-12-27
US20050014952A1 (en) 2005-01-20
AU2004249697A1 (en) 2004-12-29
PL1656360T3 (pl) 2008-01-31
DE602004008300D1 (de) 2007-09-27
EP1656360A1 (en) 2006-05-17
ATE370133T1 (de) 2007-09-15
WO2004113309A1 (en) 2004-12-29
PT1656360E (pt) 2007-10-22

Similar Documents

Publication Publication Date Title
CY1106973T1 (el) Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms)
MY142048A (en) Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)
TW200621725A (en) Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
TW200624424A (en) Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
DE60224928D1 (de) Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
MX2007011695A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
TW200606146A (en) Novel indole derivatives as selective androgen receptor modulators (SARMS)
NO20063821L (no) Kinolinderivater for anvendelse som mykobakterielle inhibitorer
AU2003276028A1 (en) Pyridine derivatives as cb2 receptor modulators
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
MXPA06000921A (es) Derivados de benzamidazoles como inhibidores de mek.
MA32544B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
DE602005010401D1 (de) Imidazolinderivate mit cb1-antagonistischer wirkung
NO20082096L (no) Azaindol-2-karboksamidderivativer
MX2007011698A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
TW200604171A (en) Novel indole derivatives as selective androgen receptor modulators (SARMs)
TW200604170A (en) Novel indole derivatives as selective androgen receptor modulators (SARMs)
ES2335410T8 (es) Derivados de aminopropanol.
MXPA06003363A (es) Derivados de fenil-piperazina como moduladores de receptores muscarinicos.
SE0300456D0 (sv) Novel compounds
CY1109371T1 (el) Παραγωγα σουλφαμικου βενζοθειοφαινιου ως αναστολεις σουλφατασης στεροειδους
ES2345882T3 (es) Nuevos compuestos y su uso como moduladores de ppar.